{"DataElement":{"publicId":"5727024","version":"1","preferredName":"Prostate Malignant Neoplasm Treatment Option Preference Type","preferredDefinition":"Information related to the prostate malignant neoplasm treatment option preferred.","longName":"PROS_MALIG_TX_OPT_PREF_TP","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"5727019","version":"1","preferredName":"Prostate Malignant Neoplasm Treatment Option Preference","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable._Alternative choices or actions.","longName":"PROS_MALIG_TX_OPT_PREF","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2443400","version":"1","preferredName":"Prostate Malignant Neoplasm","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS):A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C12410:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0AB7A5B0-A22C-4130-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-19","endDate":null,"createdBy":"PWEST","dateCreated":"2006-01-19","modifiedBy":"ONEDATA","dateModified":"2006-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5727017","version":"1","preferredName":"Therapeutic Procedure Options Preference","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:Alternative choices or actions.:The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","longName":"C49236:C25374:C41187","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Options","conceptCode":"C25374","definition":"Alternative choices or actions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preference","conceptCode":"C41187","definition":"The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BCACC2D-24E3-28A1-E053-F662850A9B9B","latestVersionIndicator":"Yes","beginDate":"2017-03-28","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-03-28","modifiedBy":"ONEDATA","dateModified":"2017-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BCACC2D-24F4-28A1-E053-F662850A9B9B","latestVersionIndicator":"Yes","beginDate":"2017-03-28","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-03-28","modifiedBy":"MORENOC","dateModified":"2017-11-30","changeDescription":"11/30/2017: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5727016","version":"1","preferredName":"Treatment Options Prefer Type","preferredDefinition":"A description of the type of treatment option preferred.","longName":"TX_OPT_PREF_TP","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unsure","valueDescription":"Uncertain","ValueMeaning":{"publicId":"2749725","version":"1","preferredName":"Uncertain","longName":"2749725v1.00","preferredDefinition":"Not established beyond doubt; still undecided or unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uncertain","conceptCode":"C47944","definition":"Not established beyond doubt; still undecided or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D3ED582-F0E6-7509-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALAIS","dateCreated":"2008-05-15","modifiedBy":"MMADDINENI","dateModified":"2022-09-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4BC1AA8A-24F7-72F2-E053-F662850AAD67","beginDate":"2017-03-28","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-03-28","modifiedBy":"ONEDATA","dateModified":"2017-03-28","deletedIndicator":"No"},{"value":"Active Surveillance","valueDescription":"Active Surveillance","ValueMeaning":{"publicId":"3238748","version":"1","preferredName":"Active Surveillance","longName":"3238748","preferredDefinition":"Taking part in an activity.: The systematic collection, analysis, and interpretation of health data on an ongoing basis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Active","conceptCode":"C45329","definition":"Exerting influence or producing an effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Surveillance","conceptCode":"C15719","definition":"The systematic collection, analysis, and interpretation of health data on an ongoing basis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A41FA3DD-99D2-2446-E040-BB89AD43483C","latestVersionIndicator":"Yes","beginDate":"2011-05-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-05-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4BC1AA8A-2502-72F2-E053-F662850AAD67","beginDate":"2017-03-28","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-03-28","modifiedBy":"ONEDATA","dateModified":"2017-03-28","deletedIndicator":"No"},{"value":"Radiation","valueDescription":"Radiation Therapy","ValueMeaning":{"publicId":"3282850","version":"1","preferredName":"Radiation Therapy","longName":"3282850","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-A183-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4BC1AA8A-250D-72F2-E053-F662850AAD67","beginDate":"2011-09-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-03-28","modifiedBy":"ONEDATA","dateModified":"2017-03-28","deletedIndicator":"No"},{"value":"Surgery","valueDescription":"Surgery","ValueMeaning":{"publicId":"2560125","version":"1","preferredName":"Surgery","longName":"2560125","preferredDefinition":"A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgery","conceptCode":"C17173","definition":"The branch of medical science that treats disease or injury by operative procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7EA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4BC1AA8A-2517-72F2-E053-F662850AAD67","beginDate":"2011-09-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-03-28","modifiedBy":"ONEDATA","dateModified":"2017-03-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5727015","version":"1","preferredName":"Therapeutic Procedure Options Preference Type","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:Alternative choices or actions.:The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.:Something distinguishable as an identifiable class based on common qualities.","longName":"C49236:C25374:C41187:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Options","conceptCode":"C25374","definition":"Alternative choices or actions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Preference","conceptCode":"C41187","definition":"The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BC1AA8A-24C8-72F2-E053-F662850AAD67","latestVersionIndicator":"Yes","beginDate":"2017-03-28","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-03-28","modifiedBy":"ONEDATA","dateModified":"2017-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BC1AA8A-24D9-72F2-E053-F662850AAD67","latestVersionIndicator":"Yes","beginDate":"2017-03-28","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-03-28","modifiedBy":"MORENOC","dateModified":"2017-11-30","changeDescription":"11/30/2017: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Which treatment option do you","type":"Preferred Question Text","description":"Which treatment option do you prefer?","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BCB458B-C1D1-5D13-E053-F662850A6E10","latestVersionIndicator":"Yes","beginDate":"2017-03-28","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-03-28","modifiedBy":"MORENOC","dateModified":"2017-11-30","changeDescription":"11/30/2017: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}